Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT00218608 · ClinicalTrials.gov registry record · Phase 2
Disulfiram for Treating Cocaine Dependence in Individuals Maintained on Methadone
A Phase 2 study, sponsored by University of Arkansas.
- Completed
- Registry status
- Phase 2
- Development phase
- 158
- Enrollment target
NCT00218608 is a Phase 2 study that has completed, run by University of Arkansas. The registered enrollment target is 158 participants.
The verdict
NCT00218608, a Phase 2 study, has completed, sponsored by University of Arkansas.
- COMPLETED
- Registry status
- Phase 2
- Development phase
- 158 participants
- Enrollment target
Study Summary
Cocaine is an extremely addictive stimulant drug that directly affects the brain. It is used in several different forms and can be snorted, smoked, or injected to achieve the desired effect. Cocaine users are at risk for many health problems, both directly and indirectly related to the effects of cocaine. Disulfiram, a drug used to treat chronic alcoholism, may be effective in reducing cocaine use. This study will evaluate the effectiveness of three different doses of disulfiram in treating cocaine dependence in opioid- and cocaine-dependent individuals maintained on methadone.
Interventions
- DRUG Disulfiram
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 158 participants |
| Start Date | 2001-04 |
| Est. Completion | 2007-01 |
| Phase | Phase 2 |
Interested in This Trial?
Full Details on ClinicalTrials.gov ↗What the Registry Record Tells You About NCT00218608
The ClinicalTrials.gov registry entry for NCT00218608 describes a study currently listed as completed, categorized as Phase 2. The registered enrollment target is 158 participants, a figure that helps gauge the scale of data the investigators plan to collect. The listed sponsor is University of Arkansas, which has 318 total studies on file at ClinicalTrials.gov.
The record links to 0 conditions, and to 1 intervention - of which Disulfiram is the first listed.
NCT00218608 reports 0 study locations.
Frequently Asked Questions
What is clinical trial NCT00218608 about?
NCT00218608 is a clinical study titled "Disulfiram for Treating Cocaine Dependence in Individuals Maintained on Methadone". Cocaine is an extremely addictive stimulant drug that directly affects the brain. It is used in several different forms and can be snorted, smoked, or injected to achieve the desired effect. Cocaine users are at risk for many health problems, both directly and indirectly related to the effects of co...
What is the current status of trial NCT00218608?
This trial is currently completed. It is a Phase 2 study. The enrollment target is 158 participants. The study started on 2001-04. Estimated completion is 2007-01.
What interventions are being tested in trial NCT00218608?
The interventions under investigation include: Disulfiram (DRUG).
Who is sponsoring clinical trial NCT00218608?
This trial is sponsored by University of Arkansas, which has 318 total clinical trials registered on ClinicalTrials.gov.
Learn More About Clinical Trials
Explore more on PlainTrial
Read our methodology - how this data is sourced, computed, and verified.
Related
Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.